摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2,6-difluorobenzyl)-3-(2-oxoethyl)-5-bromo-6-methyluracil | 352303-62-9

中文名称
——
中文别名
——
英文名称
1-(2,6-difluorobenzyl)-3-(2-oxoethyl)-5-bromo-6-methyluracil
英文别名
2-[5-Bromo-3-[(2,6-difluorophenyl)methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]acetaldehyde
1-(2,6-difluorobenzyl)-3-(2-oxoethyl)-5-bromo-6-methyluracil化学式
CAS
352303-62-9
化学式
C14H11BrF2N2O3
mdl
——
分子量
373.154
InChiKey
OKPNDHKPWLSHGW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    57.7
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(2,6-difluorobenzyl)-3-(2-oxoethyl)-5-bromo-6-methyluracil四(三苯基膦)钯三乙酰氧基硼氢化钠potassium carbonate 作用下, 以 1,2-二氯乙烷甲苯 为溶剂, 反应 2.0h, 生成 1-(2,6-Difluoro-benzyl)-5-(3-fluoro-phenyl)-6-methyl-3-{2-[methyl-(2-pyridin-2-yl-ethyl)-amino]-ethyl}-1H-pyrimidine-2,4-dione
    参考文献:
    名称:
    Synthesis and Structure−Activity Relationships of 1-Arylmethyl-5-aryl-6-methyluracils as Potent Gonadotropin-Releasing Hormone Receptor Antagonists
    摘要:
    Based on the SAR from bicyclic gonadotropin-releasing hormone (GnRH) antagonists such as 6-aminomethyl-7-aryl-pyrrolo[1,2-alpha]pyrimid-4-ones (5) and 2-aryl-3-aminomethyl-imidazolo[1,2-alpha]pyrimid-5-ones (6a,b), a series of novel uracil compounds (8) were derived as GnRH antagonists. The synthesis and SAR studies of 6-methyluracils as human GnRH receptor antagonists are discussed herein. Introduction of a small methyl substituent at the beta-position of the N3 side-chain improved the GnRH binding potency by 5-10-fold. Introduction of a methyl group of (R)-configuration at the alpha-carbon of the N-3 side-chain gave a modest improvement in binding affinity over the unsubstituted ethylene analogues. This modification enabled us to make uracil compounds without the labile 2-pyridylethyl motif on the basic nitrogen while still maintained excellent potency against the hGnRH receptor.
    DOI:
    10.1021/jm030472z
  • 作为产物:
    参考文献:
    名称:
    Identification of 1-Arylmethyl-3- (2-aminoethyl)-5-aryluracil as Novel Gonadotropin-Releasing Hormone Receptor Antagonists
    摘要:
    Based on SAR from hicyclic GnRH antagonists such as 6-aminomethyl-7-arylpyrrolo[1,2-a]pyrimid-4-ones (1) and 2-aryl-3-aminomethylimidazolo[1,2-a]pyrimid-5-ones (2a,b), a series of novel uracil compounds (4) were derived as the GnRH antagonists. Their syntheses and initial SAR are discussed herein. This is the first time that monocycle-based GnRH receptor antagonists are reported.
    DOI:
    10.1021/jm034041s
点击查看最新优质反应信息

文献信息

  • Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
    申请人:Neurocrine Biosciences, Inc.
    公开号:US20020132820A1
    公开(公告)日:2002-09-19
    GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure: 1 wherein A, Q, R 1 , R 2 , R 3a , R 3b , R 4 , R 5 , R 6 and n are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.
    GnRH受体拮抗剂被披露,可用于治疗男性和女性的各种与性激素相关的疾病。本发明的化合物具有以下结构:其中A、Q、R1、R2、R3a、R3b、R4、R5、R6和n的定义如本文所述,包括立体异构体、前药和其药用可接受盐。还披露了含有本发明化合物与药用可接受载体结合的组合物,以及与使用这些组合物拮抗需要的受试者中的促性腺激素释放激素相关的方法。
  • GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO
    申请人:NEUROCRINE BIOSCIENCES, INC.
    公开号:EP1255738B1
    公开(公告)日:2012-03-07
  • US6608197B2
    申请人:——
    公开号:US6608197B2
    公开(公告)日:2003-08-19
  • US6872728B2
    申请人:——
    公开号:US6872728B2
    公开(公告)日:2005-03-29
  • US7179815B2
    申请人:——
    公开号:US7179815B2
    公开(公告)日:2007-02-20
查看更多